Gilron, I., Tu, D., Holden, R., Towheed, T., Vandenkerkhof, E., & Milev, R. (2017). Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain. JMIR Res Protoc.
Citação norma ChicagoGilron, Ian, Dongsheng Tu, Ronald Holden, Tanveer Towheed, Elizabeth Vandenkerkhof, and Roumen Milev. "Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain." JMIR Res Protoc 2017.
Citação norma MLAGilron, Ian, et al. "Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain." JMIR Res Protoc 2017.